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Objective: Bone marrow lesions (BMLs) are a common magnetic resonance (MR) feature in patients with
osteoarthritis, however their pathological basis remains poorly understood and has not been evaluated
in vivo. Our aim was to evaluate the trabecular structure associated with the presence and size of BMLs
present in the same regions of interest (ROI) using quantitative MR-based trabecular morphometry.
Design: 158 participants in the Osteoarthritis Initiative (OAI) were imaged with a coronal 3D fast imaging
with steady state precession (FISP) sequence for trabecular morphometry in the same session as the OAI
3 T MR knee evaluation. The proximal medial tibial subchondral bone in the central weight-bearing ROI
on these knee 3D FISP images were quantitatively evaluated for apparent bone volume fraction,
trabecular number, spacing, and thickness. BMLs were also evaluated in the subchondral bone imme-
diately adjacent to the articular cartilage. BML volume was also evaluated within the same trabecular
morphometry ROI and semi-quantitatively classiﬁed as none, small, or large. KruskaleWallis test was
used to determine if mean apparent bone volume fraction, trabecular number, spacing, or thickness
differed by BML score.
Results: Compared to knees with ROIs containing no BMLs, knees with small or large BMLs had statis-
tically higher apparent bone volume fraction (P < 0.01), trabecular number (P < 0.01), and thickness
(P ¼ 0.02), and lower trabecular spacing (P < 0.01).
Conclusions: Compared to knees with ROIs containing no BMLs, knees with ROIs containing small or large
BMLs had higher apparent bone volume fraction, trabecular number and thickness, but lower trabecular
spacing. These ﬁndings may represent areas of locally increased bone remodeling or compression.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Knee osteoarthritis (OA) is a leading cause of disability among
Americans1 and is characterized by multi-tissue (e.g., cartilage,to: J.B. Driban, Division of
Street, Box #406, Boston, MA
2.
(J.B. Driban), aniat@bu.edu
edicalcenter.org (L.L. Price),
(J.A. Lynch), charles_eaton@
.org (T.E. McAlindon).
s Research Society International. Pbone) failure of a synovial joint. Processes in the peri-articular bone
(e.g., subchondral bone attrition, trabecular remodeling, osteophyte
formation, bone marrow lesions [BMLs]) appear to be an integral
part of knee OA progression2e5. Furthermore, BMLs have also been
associated with knee symptoms such as pain and stiffness3,6e8.
BMLs are common subchondral trabecular bone features in the
OA population and are identiﬁed as epiphyseal marrow regions
with high-signal intensity on fat-suppressed intermediate-
weighted (IW) or fat-suppressed T2-weighted spin echo (SE) or
turbo spin echo (TSE) magnetic resonance (MR) images9e13. BMLs
may be clinically signiﬁcant because they have been found to relate
to knee OA symptoms and structural progression3,6e8,11,14e20. Whileublished by Elsevier Ltd. All rights reserved.
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histomorphological studies have only evaluated knees with end-
stage OA prior to arthroplasty or excised tissue samples12,13,21e23.
These studies suggest that BMLs are characterized by bone marrow
necrosis, ﬁbrovascular tissue growth, reduced mineral density, and
abnormal trabeculae12,13,21e23.
High-resolution MR imaging [Fig. 1(a,b)] permits in vivo
measurement of trabecular morphology, including apparent bone
volume fraction (aBV/TV), trabecular number (aTb.N), trabecular
spacing (aTb.Sp), and trabecular thickness (aTb.Th)24e28. In this
cross-sectional study, our goal was to study bone morphological
features in subchondral trabecular regions with and without BMLs
using high-resolution MR images. We hypothesized that BMLs
represent areas of local bone remodeling and that their presence
should therefore relate to higher aBV/TV, aTb.N, and aTb.Th, but
lower aTb.Sp.Method
Study sample
This was a cross-sectional analysis of a convenience sample
from the Bone Ancillary Study (1R01AR054938) of the Osteoar-
thritis Initiative (OAI). The OAI is a multi-center observational study
of knee OA that is collecting longitudinal clinical and image data
over a 9-year period. The primary aim of the Bone Ancillary Study
was to investigate the inﬂuence of bone in the structural progres-
sion of OA. The present study is a secondary analysis of the Bone
Ancillary Study.
The Bone Ancillary Study recruited participants from the OAI
progression subcohort. To be a member of the OAI progression
subcohort each participant had at least one knee with radiographic
OA (Osteoarthritis Research Society International [OARSI] atlas
osteophyte grade 1e3)29 determined from bilateral ﬁxed-ﬂexion
radiographs as well as frequent symptoms (“pain, aching orFig. 1. Trabecular morphometry was quantiﬁed in the subchondral bone of the central med
(vertical)  13.5e17.0 mm (medialelateral)] located on 20 consecutive slices [(a) most pos
coronal IW TSE images were registered to the trabecular images, to determine the corr
b corresponds to image d).stiffness on most days of the month in the last year”); both were
assessed at the OAI baseline visit. Additional information regarding
the inclusion and exclusion criteria for the OAI progression sub-
cohort is available at http://oai.epi-ucsf.org.
Bone Ancillary Study participants were recruited at the OAI 30-
or 36-month visit from the progression subcohort at which time
they had the core OAI MR acquisitions as well as a high-resolution,
trabecular morphometry sequence performed on the primary OAI
knee (usually the right knee) at the same visit. Participants pre-
sented here are from the ﬁrst half of the Bone Ancillary Study; these
participants were recruited and imaged between August 2007 and
March 2009.MR imaging
A coronal-oblique 3D fast imaging with steady state preces-
sion (FISP) sequence [Fig. 1(a,b)]24 was obtained on the primary
OAI knee using one of four identical Siemens Trio 3 T MR systems
and a USA Instruments quadrature transmit-receive knee coil at
one of four OAI clinical sites. The primary OAI knee was usually
the right knee unless there was a contraindication (e.g., presence
of metal), in which case, the left knee was identiﬁed as the
primary OAI knee. Selection of the primary OAI knee was
advantageous because the complete set of OAI MR acquisitions
were performed on this knee, whereas the contralateral knee had
an abbreviated MR acquisition to reduce participant burden.
Therefore, the primary OAI knee was not always the knee with
symptomatic radiographic OA.
These coronal double-oblique 3D FISP images24 were used to
visualize the subchondral trabecular bone and were obtained in
10.5 min using 72 slices, 1 mm slice thickness, 0.23 mm  0.23 mm
in-plane spatial resolution, 12 cm ﬁeld of view (FOV), 512  512
matrix (interpolated to 1,024  1,024), 4.92 ms echo time (TE)
(fat-water in-phase), 20 ms recovery time (TR), 50 ﬂip angle,
180 Hz/pixel readout bandwidth, and phase encode right/left. Theial proximal tibia using high-resolution coronal 3D FISP MR images with ROI [3.75 mm
terior image and (b) most anterior image]. (c & d) To help localize the ROI and BMLs,
esponding slice range of interest (e.g., image a corresponds to image c and image
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femoral subchondral bone.
The image contrast of a FISP acquisition is determined by the
T2*/T1 ratio of the tissue, and is mostly dependent on the TR and
ﬂip angle. With the above acquisition parameters, joint ﬂuid ranges
from 20% less to 33% higher signal intensity than “normal” tibial
epiphyseal marrow (deﬁned as areas without MR evidence of BMLs,
sclerosis, fracture, cysts, or other abnormalities), whereas signal
levels inside BMLs are much lower and are often half that of
marrow. In other words, signal intensity inside BMLs is lower than
that of the joint ﬂuid. The joint ﬂuid signal intensity is location
dependent due to the radiofrequency transmit uniformity of the
knee coil30. In this image set, when mid-joint, the joint ﬂuid has
approximately 20% lower signal than the marrow. Because the fat
and water protons are in-phase at 4.9 ms TE at 3 T, the fat andwater
signal is additive and the resultant image lends itself to automated
analysis using the single threshold approach described in Newitt
et al31. Assessments in the regions of BMLs, however, should be
approached carefully because the lower ﬂuid signal levels that
occur in regions with BMLs can cause a systematic overestimation
of bone in these regions due to partial volume effects. We
attempted to minimize the impact of partial volume artifacts, by
selecting the signal value of cortical bone as our threshold.
From the core OAI knee MR protocol10 that was acquired in the
same exam session and on the same knee as the coronal 3D FISP
trabecular sequence, the sagittal fat-suppressed IW TSE series
[Fig. 2(a)] were used to score BML presence and extent3,9,10,12,32.
The IW FS TSE images were obtained using 3 mm slice thickness,
0.36 mm  0.51 mm in-plane spatial resolution, 16 cm FOV,
313  448 matrix (interpolated to 512  512), 30 ms TE,
3,200 ms TR, and phase encode superior/inferior. In addition, the
coronal non-fat suppressed IW TSE series [Fig. 1(c,d)] was used as
an orthogonal reference system to help determine extent of the ROI
and BML in the coronal plane. The coronal IW TSE images were
obtained using 3 mm slice thickness, 0.37 mm  0.46 mm in-plane
spatial resolution, 14 cm FOV, 307  384 matrix (interpolated to
512  512), 29 ms TE, 3,850 ms TR, and phase encode right/left.
Quality assessments of the MR images were performed for
contrast, FOV placement, and absence of motion artifacts. The MR
systems underwent the standard OAI quality control protocol30.
MR image analysis
The coronal 3D FISP images were quantitatively analyzed using
CalcDCN software; this analysis tool was developed and validated
at the University of California, San Francisco27,31,33e39. Brieﬂy, theFig. 2. (a) Sagittal fat-suppressed IW TSE image were used to determine the presence, locatio
[Fig. 1(c)] and posterior [Fig. 1(d)] coronal slices. The reader identiﬁed anterior and poster
representation of an axial image, with the ROI’s width [medialelateral] and depth [posteri
irregular shape represents the BML. M ¼ medial; A ¼ anterior.images were analyzed as follows. First, a standardized signal
intensity threshold was applied to the images to create a bone
mask31. The signal threshold was chosen based on the cortical bone
signal intensity from twenty circular 0.7 mm diameter ROI in the
medial and lateral femoral condyles. Next, a rectangular ROI was
placed on the 20 consecutive central MR imaging slices40 in the
proximal medial tibial epiphyseal subchondral bone, immediately
below the cartilage [Fig. 1(a)]. To improve the reliability of the
trabecular morphometry measures the ROI included the sub-
chondral cortical bone plate. The medial tibiofemoral compartment
was selected for this analysis as it has a higher prevalence of OA41
and BMLs42 compared to the lateral compartment and is exposed
to greater compressive loading43,44. The ROI had a constant height
of 3.75 mm. A single reader (AT) placed an ROI with a width of
15.0 mm and then adjusted the ROI width between 13.5 and
17.0 mm (n ¼ 50, 31.6% ROI widths were adjusted), depending on
the size of the medial tibial plateau. Apparent trabecular
morphometry (i.e., aBV/TV, aTb.N, aTb.Sp, and aTb.Th) were
calculated as previously reported38 for each ROI in each slice, and
averaged across the 20 slices. In brief, aBV/TV represents the ratio of
the number of pixels contributing to the trabecular bone signal
to the total number of pixels within the ROI. aTb.Th is the average of
the mean intercept length for all angles of parallel rays passing
through a given image and intersecting boundaries between bone
and marrow. aTb.N is the ratio between the area fraction of bone
and aTb.Th. Finally, aTb.Sp is derived from the equation (1/aTb.N)-
aTb.Th. Intra-rater (testeretest) reliability was excellent with an
intraclass-correlation coefﬁcient of 0.99 (n ¼ 12, assessed at least 3
days apart). One analyst performed all the quantitative
measurements.
BMLs were deﬁned as areas of increased signal intensity in the
bone marrow, visible on at least two consecutive slices on the
sagittal IW fat-suppressed TSE sequence, and located in the sub-
chondral bone immediately adjacent to the articular cartilage and
below the cortical bone in the proximal medial tibial epiphysis45,46.
BMLs were assigned to one of three categories based on the esti-
mated volume of the BML within the trabecular ROI: (1) “none”, if
no BML was present within the ROI; (2) “small”, if the BML
comprised 1e49% of the ROI; and (3) “large”, if the BML comprised
at least 50% of the ROI. To estimate the percentage of the ROI
occupied by a BML, the coronal 3D FISP trabecular images
[Fig. 1(a,b)] were manually registered with the coronal IW TSE
images [Fig. 1(c,d)]. The coronal IW TSE images were used as an
orthogonal reference to help localize the ROI and the BML visual-
ized on the fat-suppressed sagittal IW TSE images (e.g., sagittal
image 1a corresponds to the coronal image 1c and sagittal image 1bn and extent of the BML. Two vertical lines correspond to the locations of most anterior
ior borders of the ROI and of the BMLs using the eFILM 3D Cursor tool. (b) Pictorial
oreanterior] marked. Black line represents the outline of the proximal tibia. The grey
J.B. Driban et al. / Osteoarthritis and Cartilage 20 (2012) 1519e15261522corresponds to coronal image 1d). The range of sagittal slices
[Fig. 2(a)] that the BMLs spanned was determined by counting the
number of sagittal slices within the ROI using the eFilm 3D Cursor
tool (MERGE Healthcare, Chicago, IL). Furthermore, the reader used
the eFilm 3D Cursor tool to determine the anterior and posterior
borders of the ROI on the sagittal slices [see Fig. 2(a)]. All BML
assessments were performed by one analyst (AT) at a separate
session than when trabecular morphometry assessments were
made.
Semi-quantitative knee OA assessments
Centralized semi-quantitative assessments of radiographic knee
OA severity47 were performed using the weight-bearing posteriore
anterior ﬁxed-ﬂexion knee radiographs collected at the 24-month
OAI visit. KellgreneLawrence grades (0e4) as well as a modiﬁed
OARSI-atlas based joint space narrowing (JSN) scores29 were ob-
tained from the public data release (kxr_sq_bu, release version 3.1).
Statistical analysis
Descriptive characteristics (e.g., ethnicity, body mass index)
were calculated. The distribution of radiographic knee OA severity
was based on the centrally scored 24-month KL grade and medial
JSN scores. The absence of medial JSN was deﬁned as a JSN equal to
zero. Since the data were skewed (skewness range ¼ 0.32e3.33,
kurtosis range ¼ 0.43 to 15.06), we used the natural log of the
trabecular morphometry measures to perform four analyses of
variance (ANOVAs) to evaluate whether mean aBV/TV, aTb.N,
aTb.Sp, and aTb.Th differed by BML score. However, the model
assumptions were not met due to the data not being normally
distributed (skewness range ¼ 1.05 to 1.30, kurtosis
range ¼ 0.71e2.77), even after taking the log; therefore, we used
the nonparametric KruskaleWallis tests to evaluate if there were
differences between groups. If the P-value for the overall Kruskale
Wallis test was statistically signiﬁcant (P< 0.05), thenwe examined
all pair-wise comparisons. We also used robust regression models
with trabecular morphometry measures as the outcomes to
determine if the association between BML score and trabecular
metric outcomes held after adjusting for potential confounders,
including age, gender, ethnicity, and BMI. All analyses were per-
formed using SAS 9.2 (Cary, North Carolina, USA).
Results
The 158 subjects included in this analysis were 51.9% female,
13.3% Black, 3.2% Hispanic, and had a mean  standard deviation
age of 69.0 8.9 years, and mean body mass index of 29.2  5.0 kg/
m2. There were 149 right knees and nine left knees with a Kellg-
reneLawrence grade distribution from 0 to 4 of 13%, 15%, 33%,
29%, and 10%, respectively. The majority of participants had no
BMLs contained within the subchondral trabecular ROI: 78.5%
had no BMLs, 15.2% had a small BML, and 6.3% had a large BML.
Thirty-three participants were missing centrally-scored medial
JSN (27 with no BMLs, four with small BMLs, and two with largeTable I
Trabecular metrics [median, (min, max)] in regions with and without BMLs using Krusk
Relative BML size Log apparent bone
volume fraction
Log apparent trabecula
number (mm1)
None (n ¼ 124) 2.20 [4.42, 0.62] 0.17 [2.17, 0.63]
Small (n ¼ 24) 1.96 [2.92, 0.90]* 0.03 [0.81, 0.61]*
Large (n ¼ 10) 1.46 [2.23, 1.05]* 0.30 [0.20, 0.61]*
Overall model P-value P < 0.01 P < 0.01
*P-value of <0.05 for a pair-wise comparison with “none” as the referent group.BMLs). Among participants with no medial JSN (JSN score ¼ 0;
n ¼ 61), 97% had no BMLs, 3% had small BMLs, and 0% had large
BMLs. In contrast, a larger percent of participants with medial JSN
(n ¼ 64) had BMLs within the ROI: 59% had no BMLs, 28% had small
BMLs, and 6% had large BMLs.
The four KruskaleWallis tests evaluating trabecular morphom-
etry metrics were statistically signiﬁcant, suggestive of differences
among those with different BML sizes (Table I, Fig. 3). Compared to
ROIs without BMLs, ROIs with BMLs had higher aBV/TV (small:
P ¼ 0.0009; large: P ¼ 0.002), aTb.N (small: P ¼ 0.005; large:
P ¼ 0.004), and aTb.Th (small: P < 0.0001; large: P ¼ 0.002). ROIs
with BMLs had lower aTb.Sp compared to ROIs without BMLs
(small: P ¼ 0.006; large: P ¼ 0.0.03). The associations remained
statistically signiﬁcant even after adjusting for potential
confounders (i.e., age, gender, ethnicity, and BMI). Differences in
morphometry metrics between the small and large BML groups did
not reach statistical signiﬁcance: aBV/TV (P ¼ 0.34), aTb.N
(P ¼ 0.30), aTb.Sp (P ¼ 0.84), and aTb.Th (P ¼ 0.50).
Discussion
Using in vivo MR-based apparent trabecular morphometry
metrics we found that medial tibial trabecular characteristics of
aBV/TV, aTb.N, aTb.Th, and aTb.Sp are statistically different in the
presence of a BML. This means regions with BMLs are character-
ized by trabeculae that are thickened, increased in number, and
with less spacing. These quantitative ﬁndings are in agreement
with subjectively observed differences in the subchondral
trabecular bone on MR and radiography including sclerosis29. The
observed differences are compatible with the hypotheses that
BMLs may represent localized regions of trabecular remodeling or
compression.
The present ﬁndings concur with previous analyses of the
trabecular structure within BMLs (i.e., increased bone volume
fraction and trabecular thickness)21. In contrast to previous ﬁnd-
ings, the current measurements detected a statistically signiﬁcant
difference in aTb.N and aTb.Sp. The disparity in trabecular number
and spacing ﬁndings may be related to the differences in how the
tissues were measured (e.g., in vivo vs excised bone samples),
imaging modality (MR observes bone indirectly through changes in
the marrow signal, computed tomography [CT] observes bone
directly), spatial resolution, or sample size. Micro-CT with excised
bone samples and in vivo human peripheral CT scans can detect
smaller trabecular structures (e.g., spatial resolution of >1 microns
and 130 microns; respectively)21,48 than high-resolution in vivoMR
imaging (spatial resolution: 200 microns  200 microns 
1,000 microns)24. Though MR imaging lacks sensitivity to these
smaller trabecular structures, it may be able to focus on differences
in the larger scale structures. Furthermore, MR images can be ob-
tained with minimal risk to living participants, which facilitated
our ability to measure trabecular characteristics on a large number
of knees. The previous published study21 only included only six
patients, which may have limited their ability to detect change in
trabecular number; in contrast, 158 knees were included in the
current study.aleWallis tests
r Log apparent trabecular
thickness (mm)
Log apparent trabecular spacing (mm)
2.05 [2.30, 1.26] 0.09 [1.40, 2.22]
1.96 [2.13, 0.52]* 0.15 [1.13, 1.10]*
1.84 [2.09, 1.50]* 0.28 [1.04, 0.30]*
P ¼ 0.02 P < 0.01
Fig. 3. Box plots demonstrating the distribution of trabecular measures [(a) aBV/TV, (b) aTB.Th, (c) aTB.N, (d) aTB.Sp] in regions with no, small, or large BMLs. The boxes represent
the interquartile range of the trabecular measures and the whiskers demonstrate 1.5 times the interquartile range. Data beyond 1.5 times the interquartile range are indicated as
small boxes. The horizontal line within the box represents the median while the plus sign deﬁnes the mean.
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the central medial tibial subchondral bone and included the sub-
chondral cortical bone plate. The results of this work cannot be
generalized to trabecular morphology differences in other regions
of the knee joint or determine if the association between BMLs and
trabecular morphology changes in different regions of the knee.
However, we focused on this region because tibiofemoral OA most
frequently involves themedial compartment41. This region could be
inﬂuenced by sclerotic changes in addition to BMLs but further
research is necessary to assess the relationship between sclerotic
changes in and near BMLs21. Another limitation is that we
systematically used a small rectangular ROI independent of the size
and shape of BMLs present within a knee. This could possibly lead
to misclassiﬁcation of the BMLs, as some large BMLs may be cate-
gorized as “small” due to the small fraction of ROI they occupy.
Future studies may help clarify whether large BMLs near the
trabecular ROI inﬂuence trabecular structure. However, since the
ROI was predetermined it may be optimal to evaluate the associa-
tion between BMLs and trabecular structure using a BML score
relative to the ROI size. The ROI size varied between 13.5 mm and
17 mmwhich could inﬂuence the BML scores; however, there were
only 10 large BMLs thus minimizing the risk of misclassifying BMLs.
Another limitation is that we used a single threshold in the area
around a BML. This could potentially introduce a systematic bias
toward increased bone volume fraction in spite of the use of
a conservative threshold value taken from cortical bone. The impactof this limitation may be reduced in a longitudinal study49. Alter-
native analysis approaches are under development and valida-
tion49. The cross-sectional nature of this study constitutes another
limitation. BML presence and size can ﬂuctuate over time50 but it is
unclear if and how trabecular morphometry changes in relation to
BMLs or if the timescales/order of change are the same. Longitu-
dinal evaluations are needed to determine how changes in BMLs
size and presence relate to trabecular quantitative metrics and how
both relate to OA progression.
Another limitation to our study is that trabecular MR imaging
provides an indirect assessment of bone since the proton signal
emanating from the marrow provides a high intensity signal
whereas cortical and trabecular bone have no visible proton signal
using human in vivo MR systems. Therefore, the trabecular
measures are an assessment of the areas without high signal, and
thus are an indirect or apparent measure of trabecular morphom-
etry. Although an important limitation, the fact that these images
can be obtained in vivo allows for the conduct of longitudinal
studies and enhanced ability to include knees with little or mild
disease in studies that are both cross-sectional and longitudinal in
nature.
Using non-invasive in vivo MR imaging of knees with a range of
radiographic OA, we quantiﬁed apparent trabecular morphologic
metrics in the load-bearing tibial plateau. We found greater
apparent bone volume, trabecular number, and trabecular thick-
ness in regions with any BML size. A strength of our study is the
J.B. Driban et al. / Osteoarthritis and Cartilage 20 (2012) 1519e15261524inclusion of normal and mild radiographic OA knees; however, this
limited the number of knees with BMLs (22% of knees in this
cohort). The low prevalence of BMLs is in agreement with previous
research that indicated only 10e40% of knees with no to moderate
knee OA (KellgreneLawrence grades 0e2) have BMLs (regardless of
region)34,51. The small number of knees with BMLs in the central
medial tibia likely limited our ability to detect statistically signiﬁ-
cant differences in quantitative trabecular differences in ROIs with
small and large BMLs as well as prevented more complex modeling
to control for intra-articular lesions (e.g., meniscal pathology) or
stratiﬁed analyses (e.g., knees with or without medial JSN, knees
with or without meniscal pathology or other intra-articular lesions).
These data suggest that there are statistically signiﬁcant differ-
ences in the trabecular morphology in regions of subchondral bone
with BMLs compared to regions without BMLs. The differences may
indicate that areas of subchondral bone containing a BML are local
regions of trabecular remodeling or compression. Longitudinal
studies may help determine the causal relationships between
trabecular morphometry and BMLs.
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